SEGUIN, Texas, Jan. 2, 2024 /PRNewswire/ — Alamo Group Inc. (NYSE: ALG) announced today that its Board of Directors has declared its quarterly dividend of $0.26 per share. Payment will be made on January 29, 2024, to shareholders of record at the close of business on January 16, 2024. About Alamo Group Alamo Group is a… Continue reading ALAMO GROUP INC. DECLARES REGULAR QUARTERLY DIVIDEND
Category: Newswire
The J.M. Smucker Co. Completes the Divestiture of Fermented Condiment Brands in Canada to TreeHouse Foods
ORRVILLE, Ohio, Jan. 2, 2024 /PRNewswire/ — The J.M. Smucker Co. (NYSE: SJM) announced today the closing of the transaction to sell its Bick’s® pickles, Habitant® pickled beets, Woodman’s® horseradish and McLarens® pickled onions brands to TreeHouse Foods, Inc. (NYSE: THS). The all-cash transaction is valued at approximately $20 million USD, subject to a working… Continue reading The J.M. Smucker Co. Completes the Divestiture of Fermented Condiment Brands in Canada to TreeHouse Foods
RTX to release fourth quarter results on Jan. 23, 2024
ARLINGTON, Va., Jan. 2, 2024 /PRNewswire/ — RTX (NYSE: RTX) will issue its fourth quarter 2023 earnings Tuesday, Jan. 23, prior to the stock market opening. A conference call will take place at 8:30 a.m. ET. The conference call will be webcast live on the company’s website at www.rtx.com and will be available for replay… Continue reading RTX to release fourth quarter results on Jan. 23, 2024
Rexford Industrial Announces Dates for Fourth Quarter 2023 Earnings Release and Conference Call
LOS ANGELES, Jan. 2, 2024 /PRNewswire/ — Rexford Industrial Realty, Inc. (the “Company” or “Rexford Industrial”) (NYSE: REXR), a real estate investment trust focused on creating value by investing in and operating industrial properties located throughout infill Southern California, today announced that the Company will release fourth quarter 2023 financial results after the market closes on… Continue reading Rexford Industrial Announces Dates for Fourth Quarter 2023 Earnings Release and Conference Call
STAG INDUSTRIAL TO REPORT FOURTH QUARTER AND FULL YEAR 2023 RESULTS FEBRUARY 13, 2024
BOSTON, Jan. 2, 2024 /PRNewswire/ — STAG Industrial, Inc. (the “Company”) (NYSE:STAG) today announced that the Company will release its fourth quarter and full year 2023 operating and financial results after market close on Tuesday, February 13, 2024. The Company will host its quarterly earnings conference call on Wednesday, February 14, 2024, at 10:00 a.m.… Continue reading STAG INDUSTRIAL TO REPORT FOURTH QUARTER AND FULL YEAR 2023 RESULTS FEBRUARY 13, 2024
Regulus Therapeutics Announces Completion of Enrollment in Third Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
SAN DIEGO, Jan. 2, 2024 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the “Company” or “Regulus”), today announced it has completed enrollment in the third cohort of patients in the Phase 1b MAD study of RGLS8429 for the treatment of ADPKD. “The completion… Continue reading Regulus Therapeutics Announces Completion of Enrollment in Third Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Syndax Announces Presentation at 42nd Annual J.P. Morgan Healthcare Conference
WALTHAM, Mass., Jan. 2, 2024 /PRNewswire/ — Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer of Syndax, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024 at 5:15 p.m. PT/ 8:15 p.m. ET.… Continue reading Syndax Announces Presentation at 42nd Annual J.P. Morgan Healthcare Conference
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEWTON, Mass., Jan. 2, 2024 /PRNewswire/ — Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted 42,000 restricted stock units (RSUs) to one newly-hired employee. This RSU award was granted as of December 31, 2023 (the “Grant Date”) pursuant to the Company’s 2022 Inducement Stock… Continue reading Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages LivePerson, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LPSN
NEW YORK, Jan. 2, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of LivePerson, Inc. (NASDAQ: LPSN) between May 10, 2022 and March 16, 2023, both dates inclusive (the “Class Period”), of the important January 30, 2024 lead plaintiff deadline. SO WHAT: If you purchased LivePerson securities… Continue reading ROSEN, TRUSTED INVESTOR COUNSEL, Encourages LivePerson, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LPSN
TMX Group Completes Acquisition of VettaFi
TORONTO, Jan. 2, 2024 /PRNewswire/ – TMX Group Limited (TMX Group) today announced it has completed the acquisition of the remaining approximately 78% of the common units of VettaFi Holdings LLC (VettaFi), a leading US-based, indexing, digital distribution, analytics and thought leadership company. TMX Group made strategic investments in VettaFi in the first half of… Continue reading TMX Group Completes Acquisition of VettaFi